123 related articles for article (PubMed ID: 12699586)
1. Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease.
Hidaka Y; Kimura M; Izumi Y; Takano T; Tatsumi KI; Amino N
Thyroid; 2003 Feb; 13(2):129-32. PubMed ID: 12699586
[TBL] [Abstract][Full Text] [Related]
2. Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis.
Amino N; Hidaka Y; Takano T; Izumi Y; Tatsumi KI; Nakata Y
Thyroid; 2003 Aug; 13(8):811-4. PubMed ID: 14558923
[TBL] [Abstract][Full Text] [Related]
3. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease.
Hidaka Y; Amino N; Iwatani Y; Itoh E; Matsunaga M; Tamaki H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1667-70. PubMed ID: 8263157
[TBL] [Abstract][Full Text] [Related]
5. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
[TBL] [Abstract][Full Text] [Related]
6. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis.
Hidaka Y; Masai T; Sumizaki H; Takeoka K; Tada H; Amino N
Thyroid; 1996 Aug; 6(4):349-51. PubMed ID: 8875759
[TBL] [Abstract][Full Text] [Related]
7. Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves' disease.
Takeoka K; Hidaka Y; Hanada H; Nomura T; Tanaka S; Takano T; Amino N
Int Arch Allergy Immunol; 2003 Nov; 132(3):268-76. PubMed ID: 14646389
[TBL] [Abstract][Full Text] [Related]
8. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
Hidaka Y; Okumura M; Fukata S; Shimaoka Y; Takeoka K; Tada H; Kuma K; Amino N
Thyroid; 1999 Feb; 9(2):149-53. PubMed ID: 10090314
[TBL] [Abstract][Full Text] [Related]
9. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
[TBL] [Abstract][Full Text] [Related]
10. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
11. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
12. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
[TBL] [Abstract][Full Text] [Related]
14. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
[TBL] [Abstract][Full Text] [Related]
16. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders.
Sugenoya A; Kidd A; Row VV; Volpé R
J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990
[TBL] [Abstract][Full Text] [Related]
17. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
18. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
19. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease.
Sakata S; Tanaka S; Okuda K; Miura K; Manshouri T; Atassi MZ
Mol Cell Endocrinol; 1993 Mar; 92(1):77-82. PubMed ID: 8472870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
